Bullish
$SESN It begins to look like the stanglehold on BCG availability may force the FDA to grant early conditional approval to SESN for Vicinium to provide relief to those bladder cancer patients who are having trouble securing BCG and face radical surgery to save their lives. SESN has a solution but why do those dying patients have to wait half a year to get the life sustaining treatment? Watch closely.
  • 12
  • 3